The direct manipulation of an organism's genes, including heritable and nonheritable recombinant DNA constructions, is referred to as genetic engineering. Traditionally, humans have controlled breeding and selected offspring with desired qualities to influence genomes indirectly. The alteration of one or more genes is referred to as genetic engineering. To give an organism a desirable phenotype, a gene from another species is usually inserted to its genome. Genes can also be transferred from an animal to a plant and vice versa. GMOs, or genetically modified organisms, is another term for this. With the advent of genetic engineering, biological systems, including microbes, have been subjected to new levels of change. Genetic engineering is the bedrock of modern scientific research, and it has been used for a variety of purposes, including the production of multidrug-resistant biological weapons and viral vectors to treat human blindness. One of the drawbacks of selective breeding is that it can result in undesirable features. Scientists can use genetic engineering to implant only one gene at a time. This prevents the introduction of genes that have undesired properties. Genetic engineering also aids in the creation of new foods with desired characteristics.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States